Black Hawk Acquisition Corporation (BKHA) stock

Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Black Hawk Acquisition Corporation, updated every trading day.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

Price
$4.58
−7.29% today
Market cap
—
 
Overall quality
45/100
 
Kronos AI 30-day
+139.4%
8 of 8 simulated paths end higher

Black Hawk Acquisition Corporation (BKHA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances). It trades at $4.58, down 7.29% today, at 19.2 times earnings. Its overall quality score is 45 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +139.4% (8 of 8 simulated paths end higher).

Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership

Analyst price targets

No analyst covers this listing yet.

Kronos AI 30-day forecast

Expected close$11.83 (+139.4%)
Likely range+130.4% … +152.9%
As of2026-10-27
8 of 8 simulated paths end higher.

Quality scores

Profitability50
Solvency42
Growth44
Overall45
P/E19.2

Shariah screen

Business activityPasses
Debt and cash (AAOIFI 30%)Not checked for this listing
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.

Halal Health Care stocks · Zakat calculator · Purification calculator

For information only, not investment advice. Prices updated: 2026-10-29.